Literature DB >> 9735950

Genes involved in hereditary ataxias.

T Klockgether1, B Evert.   

Abstract

The hereditary ataxias are a group of inherited neurodegenerative disorders characterized by progressive ataxia that results from degeneration of the cerebellum and its afferent and efferent connections. Recent molecular research has led not only to the discovery of a number of causative mutations, but also shed light on the likely mechanisms by which these mutations cause the respective phenotypes. In Friedreich's ataxia (FRDA), the most common type of autosomal recessive ataxia, the loss of a mitochondrial protein, frataxin, results in overload of mitochondrial iron and oxidative stress. The autosomal dominant ataxias, spinocerebellar ataxia type I (SCAI), SCA2, SCA3 and SCA7, are caused by inheritance of an unstable, expanded CAG trinucleotide repeat. These disorders are assumed to be due to a novel deleterious function of the extended polyglutamine sequences within the proteins encoded by the respective genes. Recent observations in transgenic mice and in human post-mortem tissue suggest that the extended proteins are transported into the nucleus of neurons where they form intranuclear inclusions that disrupt normal nuclear function. In another group of dominant disorders, episodic ataxia type I and type 2 (EA-I, EA-2) and SCA6, the mutations affect genes that code for ion channels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9735950     DOI: 10.1016/s0166-2236(98)01315-0

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  9 in total

1.  Increased expression of alpha 1A Ca2+ channel currents arising from expanded trinucleotide repeats in spinocerebellar ataxia type 6.

Authors:  E S Piedras-Renteria; K Watase; N Harata; O Zhuchenko; H Y Zoghbi; C C Lee; R W Tsien
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

2.  A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions.

Authors:  M D Michelitsch; J S Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

3.  Alcohol hypersensitivity, increased locomotion, and spontaneous myoclonus in mice lacking the potassium channels Kv3.1 and Kv3.3.

Authors:  F Espinosa; A McMahon; E Chan; S Wang; C S Ho; N Heintz; R H Joho
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

4.  Analysis of calcium ion homeostasis and mitochondrial function in cerebellar granule cells of adult CaV 2.1 calcium ion channel mutant mice.

Authors:  Bhupinder Bawa; Louise C Abbott
Journal:  Neurotox Res       Date:  2008-01       Impact factor: 3.911

5.  Expression of expanded polyglutamine protein induces behavioral changes in Drosophila (polyglutamine-induced changes in Drosophila).

Authors:  Yun-Taik Kim; Sang Min Shin; Won Yong Lee; Gyeong-Moon Kim; Dong Kyu Jin
Journal:  Cell Mol Neurobiol       Date:  2004-02       Impact factor: 5.046

6.  A SEL1L mutation links a canine progressive early-onset cerebellar ataxia to the endoplasmic reticulum-associated protein degradation (ERAD) machinery.

Authors:  Kaisa Kyöstilä; Sigitas Cizinauskas; Eija H Seppälä; Esko Suhonen; Janis Jeserevics; Antti Sukura; Pernilla Syrjä; Hannes Lohi
Journal:  PLoS Genet       Date:  2012-06-14       Impact factor: 5.917

Review 7.  Neuronal nitric oxide synthase expression in cerebellar mutant mice.

Authors:  Louise C Abbott; Sang-Soep Nahm
Journal:  Cerebellum       Date:  2004       Impact factor: 3.648

8.  Polyglutamine toxicity in yeast induces metabolic alterations and mitochondrial defects.

Authors:  Katharina Papsdorf; Christoph J O Kaiser; Adrian Drazic; Stefan W Grötzinger; Carmen Haeßner; Wolfgang Eisenreich; Klaus Richter
Journal:  BMC Genomics       Date:  2015-09-03       Impact factor: 3.969

Review 9.  microRNAs: tiny regulators of synapse function in development and disease.

Authors:  Silvia Bicker; Gerhard Schratt
Journal:  J Cell Mol Med       Date:  2008-07-08       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.